http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2814393-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25d057e1adedc87fd5ec6ee3aa3d6cf3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1455
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
filingDate 2013-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1c8b69ff3e1f845f0a29b3ffa3430b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ab8799a4d4a12450181806ba149982a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1176651d8001fd3aaa54d303eea31ef5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65fc7b1cfc1ba78727a5360e838974fe
publicationDate 2014-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2814393-A1
titleOfInvention Compositions and methods for monitoring biometric indicators
abstract Methods of measurement of biometric indicators in a mammalian subject are described. Biometric indicators of interest include hematocrit, plasma volume, volume of distribution, and glomerular filtration rate. The methods are especially applicable to subjects with rapid blood loss and to subjects with unstable hematocrits. Hematocrit may be measured by administering an injectate with a dynamic fluorescent marker and a static fluorescent marker, or a single static marker with two fluorescent tags, into the vascular system of the subject, and monitoring the emission intensities of the markers or fluorescent tags over a period of time. Hematocrit may then be calculated using a calibrated spectrometric analyzer by determining the raw ratio of the markers at T0, calculating the apparent hematocrit, and applying a correction factor.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016210311-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3313286-A4
priorityDate 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010127136-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006113724-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009285761-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011318712-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406479

Total number of triples: 35.